Healthcare Data Room Checklist: Folder Structure and Documents Buyers Expect
A healthcare data room should open with a Read Me First file and seven numbered folders: corporate, financial, revenue cycle, regulatory, people, contracts and IT/privacy. Inside them sit the 30 documents buyers expect, listed below with the red flag for each. Keep PHI out by default. Release documents in stages tied to the NDA, IOI and LOI. When the buyer competes with you, send payer rates and physician pay through a clean team.
The room also affects how much of your price is held back. In SRS Acquiom's 2026 Deal Terms for M&A Escrows, which covers 2025 deals across all industries, median total escrow was 11.1% of transaction value on deals without reps and warranties insurance (RWI) and 2.8% on deals with it.
Data as of November 20, 2026. Every figure below is linked to its source, with the population and period stated beside it.
The 7-folder index and the Read Me First file
Numbered folders, consistent file names and a one-page guide tell a buyer the company is well run. A room of 300 loose PDFs tells them to expect surprises. Every document a buyer cannot find becomes a Q&A request, and every slow answer becomes a reason to re-price.
| Folder | Contents | Opens at |
|---|---|---|
| 00 Read Me First | Index, naming convention, Q&A process, staging schedule | Phase 1 |
| 01 Corporate and Ownership | Entities, cap table, governance, MSO/PC structure, enrollment | Phase 1 |
| 02 Financial and Tax | Financials, tax returns, EBITDA bridge, debt | Phase 1 (summary), Phase 2 (detail) |
| 03 Revenue Cycle and Payers | AR, payer mix, coding audits, refunds, exclusion screening | Phase 2 |
| 04 Regulatory and Compliance | Licenses, compliance program, inquiries, transaction review memo | Phase 1 (licenses), Phase 2 (rest) |
| 05 Providers and People | Physician agreements, covenants, census, benefits, credentialing | Phase 1 (anonymized census), Phase 2 |
| 06 Contracts, Real Estate and Equipment | Material contracts, leases, equipment, referral and director arrangements | Phase 2 |
| 07 IT, Privacy and Security | HIPAA risk analysis, incident log, BAAs, systems | Phase 1 (summary), Phase 2 |
| 99 Clean Team (restricted) | Payer rates, named compensation, referral volumes | Clean team only |
Name files [folder].[sub].[seq]_[document]_[date]. Buyers cite file numbers in their Q&A, and the same numbers carry into the disclosure schedules.
Sample index excerpt (illustrative, single-specialty physician group)
00.0.01_Read_Me_First_2026-11-01
01.1.01_Entity_Chart_2026-10-15
01.2.01_Cap_Table_Fully_Diluted_2026-10-15
01.4.01_Management_Services_Agreement_MSO-PC_2022-03-01
01.5.01_Medicare_Enrollment_Ownership_Reconciliation_2026-10-20
02.1.01_Monthly_Financials_2023-01_to_2026-09
02.3.01_EBITDA_Bridge_v3_2026-10-30
03.1.01_AR_Aging_by_Payer_2026-09-30
03.2.04_BCBS_Agreement_2025-01-01 (fee schedule in 99)
03.4.01_Exclusion_Screening_Log_2023-01_to_2026-10
05.1.03_Physician_Agreement_Provider-C_2024-07-01 (named in Phase 2)
06.3.02_Equipment_Register_and_Service_Contracts_2026-09-30
07.1.01_HIPAA_Risk_Analysis_2026-06-15
Mapping a buyer request list to the room
Buyers send request lists of their own. Answer each line with a file number, not a paragraph.
| Typical buyer request | Checklist item | File | Stage |
|---|---|---|---|
| "Provide a fully diluted cap table and all ownership agreements" | 2 | 01.2.01, 01.3.x | Phase 1 |
| "Reconcile Medicare enrollment ownership to the cap table" | 5 | 01.5.01 | Phase 1 |
| "Support for each EBITDA adjustment" | 7 | 02.3.01 plus invoices in 02.3.x | Phase 2 |
| "AR aging by payer, last 36 months" | 8 | 03.1.01 | Phase 2 |
| "Exclusion screening for all providers, staff and vendors" | 14 | 03.4.01 | Phase 2 |
| "All physician compensation arrangements and FMV support" | 21 | 05.1.x, 05.2.x (named pay in 99) | Phase 2, clean team |
| "Major equipment, age, ownership and service history" | 26 | 06.3.02 | Phase 2 |
| "Security incidents in the last five years" | 29 | 07.2.01 | Phase 2 |
What each buyer type opens first
Build one room for every buyer. Expect the questions to follow the buyer type.
| Buyer type | Opens first | Have ready before they ask |
|---|---|---|
| PE platform buying an add-on | Payer contracts, provider census, folder 99 | Rate comparison by top payer, provider-level production, integration overlap list |
| PE sponsor buying a new platform | EBITDA bridge, management depth, MSO/PC structure | Second-tier management bios, scalable billing and credentialing processes |
| Growth or recap investor | Cap table, governance, budget, use of proceeds | Pro forma cap table after the raise, board and consent rights, three-year plan |
| Strategic acquirer | Systems, integration cost, payer and referral overlap | EHR and PM contracts with termination terms, data migration scope |
| Hospital or health system | Carve-out scope, shared services, stand-alone costs | Stand-alone P&L, overhead allocation method, transition services list |
| Family office or long-hold investor | Governance, distributions, owner transition | Distribution history, owner pay policy, succession plan, five-year capex schedule |
Recaps and minority raises. When the process sells equity to investors rather than the whole company, the room also has to support the offering itself. The structure questions are covered in capital raising for healthcare companies. Two free public tools help both sides prepare. SEC EDGAR full-text search shows Form D notices filed by private issuers, so you can see which healthcare companies in your niche have raised private capital. FINRA BrokerCheck shows the registration and disclosure history of any firm or banker introducing investors. How to choose a healthcare investment banker explains what that changes.
Carve-outs. Kaufman Hall's Q3 2026 M&A Quarterly Activity Report release (October 13, 2026) reports that divestitures made up nearly one-third of the 16 hospital and health system transactions announced in Q3 2026. A carve-out room needs stand-alone financials for the divested unit, the method used to allocate shared overhead, and a list of every service the parent will provide under a transition services agreement after closing.
Checklist items 1 to 10: corporate, ownership and financial proof
| # | Item | Why buyers care | Document or proof | Red flag |
|---|---|---|---|---|
| 1 | Read Me First and index | Cuts review time and question volume | One-page guide, full index, Q&A contact | No index, folders named by staff initials |
| 2 | Entity chart and cap table | The buyer prices only what it can trace | Entity chart, fully diluted cap table, operating or shareholder agreements | Unsigned agreements, owners missing from the cap table |
| 3 | Governance and authority | Confirms who can approve a sale | Formation documents, good standing certificates, minutes, consents | Lapsed good standing, no consent rights mapped |
| 4 | MSO and PC structure | Corporate practice of medicine exposure | Management services agreement, PC ownership, stock transfer restriction agreement | Management fee with no FMV support |
| 5 | Medicare and Medicaid enrollment | Billing depends on enrollment records that match real ownership | Enrollment records, ownership disclosures on file, history of reported changes | Enrollment ownership does not match the cap table |
| 6 | Three years of monthly financials and tax returns | Baseline for the QoE | General ledger, trial balances, financial statements, returns | Cash and accrual figures that do not reconcile |
| 7 | EBITDA adjustment bridge | Every add-back gets tested | Add-back schedule with invoices and support | Owner pay added back with no market replacement cost |
| 8 | AR aging by payer | Shows how good and how collectible revenue is | Aging report, collections, denial rates | Large balances over 120 days |
| 9 | Payer mix, three years | Buyers price revenue quality by payer class | Revenue by payer class and top payers, with three-year trend | Payer concentration or a shifting mix the seller cannot explain |
| 10 | Debt, liens and guarantees | Sets the payoff at closing | Loan documents, UCC search, payoff letters | Personal guarantees not disclosed |
Why item 9 gets so much attention. Payer classes differ in size and in rate risk. Per the CMS National Health Expenditure fact sheet, 2024 U.S. private health insurance spending was $1,644.6 billion (31% of total health spending) and Medicare spending was $1,118.0 billion (21%). Physician and clinical services spending grew 8.1% to $1,109.7 billion in 2024. A buyer reads your mix against those pools and against the reimbursement exposure each one carries.
Item 9 benchmark, dermatology only. FOCUS Investment Banking's Dermatology Practice Valuation: 2026 Benchmarks reports that dermatology buyers prize practices with more than 70% commercial or cash-pay revenue, citing revenue quality, faster collections and protection from government reimbursement cuts. That is a stated buyer preference in one specialty, not a valuation floor or a pass/fail line. Home health, hospice and other Medicare-heavy sectors are judged against their own norms.
Worked example for item 9 (our arithmetic, illustrative dermatology practice). The practice collects $12.0 million: $7.2 million commercial, $1.2 million cash-pay, $2.4 million Medicare and $1.2 million Medicaid. Commercial plus cash-pay is $8.4 million, or 70.0% of collections ($8.4M ÷ $12.0M). That sits at the FOCUS line, not above it. The folder 03 schedule should show the three-year trend, because a rise from 64% to 70% reads very differently from a fall from 76% to 70%.
Items 6 to 8 feed the quality of earnings work. The QoE prep checklist covers the test procedures.
Checklist items 11 to 20: revenue cycle, compliance and clinical operations
This is where healthcare rooms differ from general M&A rooms. Buyers read this section for liabilities that survive closing.
| # | Item | Why buyers care | Document or proof | Red flag |
|---|---|---|---|---|
| 11 | Licenses, permits, accreditation | The business cannot operate without them | State licenses, DEA registrations, CLIA, accreditation letters | Expired or wrong-entity licenses |
| 12 | Commercial payer contracts | Revenue durability and assignment rights | Contracts and amendments (fee schedules go to folder 99) | Change-of-control termination rights |
| 13 | Coding audits and refund log | Overpayment exposure and refund discipline | Internal and external audits, corrective actions, refund log, payer correspondence | No audit in three years, credit balances held for years |
| 14 | Exclusion screening | An excluded person on claims creates repayment exposure | Monthly screening logs against the HHS OIG exclusion list, SAM.gov and state Medicaid lists, covering providers, staff and vendors | Screening only at hire, or no vendor screening |
| 15 | Compliance program | Shows compliance has been managed over time | Policies, training records, hotline log, compliance officer minutes | Policies written last month |
| 16 | Government inquiries and litigation | Contingent liabilities | Subpoenas, CIDs, audit letters, demand letters, settlement files | Inquiry disclosed late in diligence |
| 17 | Transaction review memo | Federal and state transaction reviews can set the earliest closing date | Memo covering every state where the target or buyer operates, plus federal premerger review | No memo before LOI |
| 18 | Ownership history since enrollment | Buyers test whether billing privileges carry through the deal, and recent ownership changes draw extra questions in home health and hospice | Dated history of every ownership and structure change since enrollment | Undocumented ownership change in recent years |
| 19 | Clinical operations and quality | Supports payer contracting, value-based terms and survey readiness | Credentialing and privileging files, peer review summaries, infection control and clinical policies, quality reports, survey results | Lapsed credentialing, quality data the seller cannot reproduce |
| 20 | Malpractice and incident history | Insurance cost and tail coverage | Loss runs, open claims, policy declarations | Gaps between claims-made policies |
Item 17: build the closing calendar before the LOI
Healthcare deals can face several state and federal transaction reviews, each on its own clock. The longest one sets the earliest closing date. A seller who learns this after signing an LOI has given up exclusivity time it cannot get back.
| Calendar input | Owner | Data room source | Start |
|---|---|---|---|
| States where the target and buyer operate or hold licenses | Seller | Items 2, 11 | Day 1 of prep |
| Revenue and ownership facts the review analysis needs | Seller CFO | Items 2, 6 | Day 1 of prep |
| Notice and review analysis, state and federal | Deal counsel | Item 17 memo | Before the teaser goes out |
| Payer and contract consents needed at closing | Seller | Items 12, 25 | Before LOI |
| Earliest realistic closing date | Deal lead | All of the above | Written into the LOI timeline |
Put the item 17 memo in the room in Phase 2. Buyers will ask for it, and a seller who already has it controls the timeline discussion. The sequence is covered in the healthcare M&A process guide.
Gap triage before launch: fix, explain or disclose early
The scoring rule below will turn up gaps. Each one needs a decision before Phase 1 opens: fix it, explain it with a short memo, or disclose it early and propose how it will be handled. Record the decision in the Q&A log with one owner and a finish date.
| Gap pattern | Example items | Default decision | What goes in the room | Owner | Finish by |
|---|---|---|---|---|---|
| Document exists but is unsigned, expired or in the wrong entity name | 2, 11, 21, 26, 27 | Fix | The signed, current version, with the superseded copy in an archive subfolder | Folder owner | Before Phase 1 |
| Support exists but is scattered across inboxes and drives | 7, 13, 26 | Fix | One schedule that cites a file number for every invoice, audit or asset record | CFO or operations lead | Before the CIM |
| A figure in the CIM cannot be rebuilt from source systems | 6, 8, 9, 19 | Fix or drop | A report tied to the general ledger or PM system, or the figure removed from the CIM | CFO | Before the CIM |
| Historical issue already resolved | 13, 16, 29 | Explain | One-page summary with dates, scope, corrective action and closing correspondence | Compliance officer | Phase 2 opening |
| Process that started late | 14, 15, 28 | Explain | Current logs plus the completed lookback, with the start date stated plainly | Compliance or privacy officer | Before Phase 1 |
| Open matter with an unknown cost | 16, 17, 18, 22 | Disclose early | Summary memo, a cost range if one exists, and the proposed handling (price, escrow or special indemnity) | Deal lead with counsel | Before LOI |
Test for the decision. If a buyer will find the gap in Phase 2 anyway, put a summary of it in Phase 1. A gap the seller raises first is negotiated as a known cost. The same gap found by the buyer is negotiated as a question about everything else in the room.
What fixing costs against what finding costs (our arithmetic, using the worked example later on this page). Pulling invoices and an engagement letter to support a $400,000 add-back (item 7) takes days of staff time. Left unsupported, the same add-back is removed in diligence and, at the assumed 9.0x multiple, cuts enterprise value by $3.6 million. Rank the fix list by that logic: multiply each unsupported EBITDA item by your expected multiple, and work the largest numbers first.
Where a gap touches physician pay, medical director fees or the MSO/PC structure (items 4, 21 and 27), read healthcare compliance due diligence guide, and for item 17 read healthcare M&A process guide. Take the specific questions from both to your own attorney before the gap is classified.
Checklist items 21 to 30: physician agreements, contracts, equipment and HIPAA proof
| # | Item | Why buyers care | Document or proof | Red flag |
|---|---|---|---|---|
| 21 | Physician compensation agreements | Physician referral and kickback exposure | Signed agreements, comp formulas, FMV opinions | Expired or unsigned agreements, pay that moves with referrals |
| 22 | Restrictive covenants | Protects the earnings the buyer is paying for | Non-competes and non-solicits by provider, with state, signing date and the provider's ownership position | Covenants presented as protection in the CIM with no review of whether they will hold |
| 23 | Provider and staff census | Retention risk and key-person exposure | Roster with role, tenure, FTE, pay band (names withheld in Phase 1) | Revenue concentrated in one or two providers |
| 24 | Payroll and benefits | Wage-hour and plan liabilities | Benefit plans, 5500s, classification review | Contractors doing employee work |
| 25 | Material contracts | Assignment and change-of-control consents | Contract summary with consent column | Key vendor with termination right on sale |
| 26 | Real estate and major equipment | Occupancy cost, related-party rent and near-term capex | Leases, rent roll, appraisal for owner-held real estate, equipment register with age, ownership or lease status, and service contracts | Related-party rent above market, imaging or surgical equipment near end of life with no capex plan |
| 27 | Medical director and referral source arrangements | Physician referral and kickback exposure | Written agreements, time logs, FMV support | Payments with no time logs |
| 28 | HIPAA risk analysis and policies | Shows the security program actually runs | Current risk analysis, remediation plan, policies | Risk analysis older than the current EHR |
| 29 | Security incident and breach log | Undisclosed incidents become indemnity claims | Incident log with dates, scope, notifications (no patient identities) | Ransomware event missing from the log |
| 30 | BAAs and system inventory | Vendor risk and integration cost | BAA register, EHR and PM systems, data map | Vendors handling PHI with no BAA |
Items 21, 22 and 27. The room's job is to make each arrangement easy to test. Build one row per provider or arrangement, with the signed agreement, the comp formula, the FMV support and the covenant terms side by side. Buyers discount revenue from any provider whose agreement or covenant they cannot rely on, so an unsigned renewal costs more than the paperwork to fix it.
Items 23 and 24. Check your pay bands before a buyer does. The BLS Health Care and Social Assistance industry page carries current official employment and wage data for the sector. A census whose pay bands sit well off market invites questions about retention cost after closing.
Healthtech and AI-enabled sellers. Nearly 20% of eHealth transactions completed in 2025 targeted companies with AI-enabled services, according to LevinPro HC data reported by FOCUS Investment Banking. These buyers want three more files in folder 07: the source of every training dataset, the contract or BAA term that permits each use of patient data, and model validation records. A model built on data the seller cannot show a right to use becomes a rep the buyer will want backed by a special indemnity.
The healthcare compliance due diligence guide shows how buyers test items 21 and 27.
What missing documents cost
Buyers rarely walk away over a single gap. They move the cost to the seller. The response depends on whether the gap can be measured.
| Gap found in diligence | Typical buyer response | Where it lands |
|---|---|---|
| Add-back with no support (item 7) | Removed from EBITDA, price cut at the deal multiple | Purchase price |
| Unsigned or expired physician agreement (item 21) | Closing condition to re-paper, special indemnity for the past period | Purchase agreement |
| Screening gap (item 14) | Lookback required before signing, specific escrow for any repayment | Escrow |
| Covenant the buyer cannot rely on (item 22) | Provider's revenue moved into an earnout or rollover | Deal structure |
| Undisclosed incident (item 29) | Special indemnity, often outside RWI coverage | Indemnity |
| Payer contract with change-of-control termination (item 12) | Consent made a closing condition | Timing |
Worked example (our arithmetic, illustrative figures). A practice presents $5.0 million of adjusted EBITDA, including a $400,000 add-back for a "one-time" consulting project. The seller has no invoices or engagement letter to support it. The buyer removes it, and adjusted EBITDA falls to $4.6 million. At an assumed 9.0x multiple, enterprise value drops from $45.0 million to $41.4 million, a $3.6 million cut ($400,000 × 9.0). On a cash-free, debt-free deal, the seller's equity proceeds fall by the same $3.6 million before fees. The multiple is an assumption for illustration, not market data.
PHI controls for the data room
Most of the 30 items can be proven without any PHI. Two layers decide what goes in: what privacy law permits for this buyer and deal structure, and the stricter policy most sellers adopt on top of it.
| Layer | What it says | How it shows up in the room |
|---|---|---|
| Privacy law | Whether a diligence disclosure fits this buyer and structure, and how much data is enough, is a question for your own attorney | Answered in writing before any sample is shared |
| Minimum data principle | Share only what the test requires | Fixed samples sized to the test, never full exports |
| Seller policy (stricter than the default) | De-identified data by default, PHI only as an approved exception | Phase 1 and most of Phase 2 carry no PHI at all |
| Contract and platform controls | NDA terms, permission groups, view-only access, watermarks, download blocks | Applied to every folder that holds samples |
The seller policy exists because a failed deal leaves PHI with a party that is not buying the business. Treat it as risk management, not as a statement of what the law allows.
Operating rules for the room:
- No PHI in the room by default. Prove revenue, payer mix and coding from aggregated reports.
- Redact identifiers from every sample. Coding audit samples, incident reports and denial files go in only with identifiers stripped.
- Run claim-level testing as a controlled exercise. Use a fixed sample, named reviewers, view-only access, watermarks and a separate permission group, with written approval from the privacy officer.
- Turn off downloads on folders 03, 05 and 07. Keep the audit log on and review it weekly.
- Assign one gatekeeper. One person on the seller side approves every upload to folders 03, 05, 07 and 99.
- Scrub metadata. Spreadsheets carry hidden tabs, comments and patient names in filter lists. Check before upload.
Staged disclosure: 5 gates from teaser to signing
Keep the room open at the top and tight at the bottom. These gates reflect market practice.
| Stage | What opens | Gate | Who sees it |
|---|---|---|---|
| 1. Teaser | Anonymized profile, specialty, region, revenue band | None | Any qualified buyer or family office |
| 2. CIM | Financial summary, payer mix, provider count | NDA | Deal team |
| 3. Phase 1 room | Items 1 to 11, 19 summary, 23 (anonymized), 28 summary | NDA plus process letter | Buyer deal team, lenders |
| 4. Phase 2 room | All items except folder 99 | Signed LOI with exclusivity | Buyer, its advisors, QoE firm, RWI underwriter |
| 5. Clean team | Payer fee schedules, named comp, referral volumes | Clean team agreement | Named outside advisors only |
See the healthcare M&A timeline chart. The healthcare M&A process guide maps these gates against the full process.
Clean team rules for competitively sensitive data
The buyer across the table often already operates in your market. Of the 1,029 private equity-backed healthcare deals the Private Equity Stakeholder Project tracked in 2025, 664 were add-on acquisitions, 151 were leveraged buyouts and 214 were growth investments. Add-ons were about 65% of the total (our arithmetic: 664 ÷ 1,029). PESP built the count from PitchBook and LevinPro HC data and describes it as likely an undercount. In outpatient care, PESP data reported by Becker's ASC Review shows 119 add-ons among 148 deals in 2025, about 80% (our arithmetic: 119 ÷ 148). Dermatology led outpatient subsectors with 24 deals, followed by eye care (22) and oncology (9). If you sell in one of those specialties, plan for a buyer that already contracts with your payers.
That buyer recruits from your provider pool and negotiates with your payers. Once its operators have seen your rates and pay data, that knowledge stays with them if the deal fails. Three separate controls address this, and a seller needs all three:
| Control | What it does | What it does not do |
|---|---|---|
| Clean team agreement | Defines who may see folder 99 and what they may pass on | Does not decide what competitors may lawfully exchange |
| Operational separation | Keeps clean team members out of pricing, contracting and recruiting roles, with separate systems access | Does not work if the agreement names the wrong people |
| Antitrust analysis | Decides what can be shared at all and what control the buyer may take before closing | Sits with your own attorney, not in the data room |
- Folder 99 holds: fee schedules by payer and CPT, named provider compensation, referral source volumes, growth pipeline and pricing strategy.
- Clean team members: outside advisors and QoE accountants. Add buyer employees only if they have no pricing, contracting or recruiting role.
- Output rule: reviewers report aggregated conclusions to the buyer's business team, such as "rates are at or above market across top five payers." They pass on no rates or names.
- Timing rule: integration planning that touches pricing, payers or staffing stays behind the clean team until closing.
- Exit rule: if the deal breaks, the agreement requires return or destruction of folder 99 material and written certification.
How the room shapes escrow and indemnity
Disclosure schedules are drafted for the purchase agreement, but they are built largely from what the room contains. A clean, indexed room makes the schedules faster to draft and easier to check against the reps. Problems that surface after closing are settled against those reps and schedules. Across the deals covered by SRS Acquiom's 2026 Deal Terms for M&A Escrows, 28% had indemnification claims, excluding purchase price adjustments. The escrow figures below cover 2025 deals across all industries, not healthcare alone.
| Escrow, % of transaction value (SRS Acquiom, 2025 deals, all industries) | Without RWI: mean | Without RWI: median | With RWI: mean | With RWI: median |
|---|---|---|---|---|
| Total escrow | 14.7% | 11.1% | 5.1% | 2.8% |
| General indemnification escrow | 11.3% | 10.0% | 2.2% | 0.5% |
Worked example (our arithmetic, $40 million transaction value, SRS Acquiom 2025 medians applied to that value). The general indemnification escrow is a component of total escrow, so the two rows are not additive.
| Measure | Without RWI | With RWI | Difference |
|---|---|---|---|
| Total escrow | $4.44M (11.1%) | $1.12M (2.8%) | $3.32M |
| General indemnification escrow | $4.00M (10.0%) | $0.20M (0.5%) | $3.80M |
The with-RWI and without-RWI medians come from different sets of deals. The gap shows how the market sets holdbacks across those cohorts, not what buying RWI alone would save on your deal. Net the RWI premium and retention against the smaller escrow before comparing. Underwriters work from the buyer's diligence reports, so topics the buyer could not diligence are candidates for exclusion. Buyers then ask the seller to cover excluded matters through a special indemnity or escrow. A complete room shrinks that list.
Earnouts raise the stakes on the same documents. In SRS Acquiom's 2026 M&A Earnout and Milestone Trends, U.S. private equity buyers used earnouts in 24% of their 2025 deals in the dataset, up from 13% across 2014 to 2022. U.S. public buyers used them in 18% of 2025 deals, against 15% in the earlier period.
Worked example (our arithmetic, illustrative terms, not market data). A seller takes $25 million at closing plus a $5 million all-or-nothing earnout if 2027 EBITDA reaches $4.5 million. The business delivers $4.5 million under the seller's add-back method. After closing, the buyer treats $300,000 of former add-backs as recurring costs. Measured EBITDA falls to $4.2 million and the earnout pays zero. The seller loses $5 million, or 16.7% of the $30 million headline consideration ($5M ÷ $30M). The fix starts in the data room. Put the item 7 bridge in folder 02 and have the purchase agreement reference it as the measurement method.
Run your numbers in the deal proceeds calculator.
Q&A log discipline
Buyers judge responsiveness as closely as the documents. Run the Q&A through the data room platform, not email.
| Practice | Standard |
|---|---|
| One log | Every question numbered, dated, assigned and linked to the file that answers it |
| Response time | Set a target in the Read Me First file and meet it |
| Answer with a document | Upload the support and cite the file number rather than writing a narrative |
| Same answer to every bidder | Repeat questions get the same answer, logged once and released to all |
| Weekly review | Seller lead reviews open items and access logs together |
Folder owners and sign-off checks before Phase 1 opens
Rooms stall when nobody owns a folder. Give each folder one named owner on the seller side, a known source system and a check that must pass before anything is uploaded. The gatekeeper from the PHI operating rules approves uploads across all of them.
| Folder | Seller owner | Pulls from | Sign-off check before upload |
|---|---|---|---|
| 00 Read Me First | Deal lead | Index export from the data room platform | Every file number in the index opens, Q&A contact and response target stated |
| 01 Corporate and Ownership | CEO with corporate secretary | Minute book, cap table ledger, enrollment records | Cap table ties to signed agreements and to enrollment ownership (item 5) |
| 02 Financial and Tax | CFO or controller | General ledger, tax returns, QoE workpapers | Monthly financials tie to returns, every add-back has an invoice behind it |
| 03 Revenue Cycle and Payers | Revenue cycle director | PM system, clearinghouse, payer portals | AR aging ties to the balance sheet, samples redacted, fee schedules moved to 99 |
| 04 Regulatory and Compliance | Compliance officer | License files, compliance binder, item 17 memo | Every license current and in the right entity name |
| 05 Providers and People | HR lead with the medical staff office | Payroll, HRIS, credentialing files | Census anonymized for Phase 1, every physician agreement signed and dated |
| 06 Contracts, Real Estate and Equipment | Operations lead | Contract files, leases, asset register | Consent column complete, equipment register ties to the fixed asset ledger |
| 07 IT, Privacy and Security | Privacy and security officer | Risk analysis, incident tickets, vendor list | Incident log carries no patient identities, BAA register matches the vendor list |
| 99 Clean Team | Deal lead | Payer fee schedules, compensation files | Access limited to named clean team members, downloads off |
If the business runs through a management services organization, split ownership of folders 01 and 05 between the MSO and the PC. The structure is covered in management services organizations.
Before the room opens, each owner confirms in writing that their folder passed its check. Keep those confirmations in the Q&A log so the weekly review starts from a known baseline.
Scoring rule: count the items you can prove today
This is a focused 30-item checklist built around the documents that most often move price, structure or timing. A buyer's full request list will run longer. Give yourself one point for each item where the document exists, is signed, is current and sits in the right folder today. The maximum score is 30. The bands below are our working standard, not an industry benchmark.
| Score | Status | Action |
|---|---|---|
| 27 to 30 | Launch-ready | Open Phase 1 on schedule |
| 20 to 26 | Fixable | Close gaps before the CIM goes out |
| Below 20 | Not ready | Delay launch. Gaps that buyers find become price cuts |
Hard-stop items. Items 4, 5, 14, 16, 21 and 27 override the total. A gap in any of them means Not ready at any score, because each one changes structure or price, not just timing. A practice that scores 28 but has unsigned physician agreements (item 21) is not launch-ready.
30/60/90-day order of work
Days 1 to 30. Build the index and naming convention, the entity chart and cap table (items 1 to 3). Pull three years of financials and returns. Check enrollment records against ownership (items 5 and 18). Run a full exclusion screening lookback (item 14). Commission the transaction review memo (item 17) so every clock is known before any LOI.
Days 31 to 60. Collect and sign every physician, medical director and lease agreement (items 21, 26, 27). Commission FMV support where it is missing. Build the covenant schedule (item 22) and the equipment register with a capex view (item 26). Complete the coding audit and clear the refund log (item 13). Bring credentialing files current (item 19). Update the HIPAA risk analysis and BAA register (items 28, 30).
Days 61 to 90. Finish the EBITDA bridge (item 7) with support for every add-back, in the form you want referenced for any earnout. Redact samples and set permission groups by stage. Draft the clean team agreement and load folder 99. Run a mock diligence pass with an outside reviewer, working from a real buyer request list, and fix anything they cannot find in under five minutes.
The sell-side readiness checklist covers the operating fixes that should happen before the room opens. The buyer due diligence checklist shows the request list you will receive.
Questions owners ask
Should patient records ever go into a healthcare data room?
Not by default. Buyers can check revenue, payer mix, coding accuracy and quality from aggregated or de-identified data. When a buyer needs claim-level testing, run it as a controlled sample. Redact identifiers, limit access to named reviewers and turn off downloads. Keep raw EHR exports, charts and patient lists out of the general room entirely.
Do federal health privacy rules allow a seller to share PHI with a buyer during diligence?
The answer depends on the buyer, the deal structure and the data involved, so take the question to your own attorney before any sample is shared. Most sellers keep the question small. They use de-identified data by default and treat any PHI sample as a documented exception, sized to the test and approved in writing by the privacy officer.
When should a seller open the data room?
Build the full room before launch and open it in stages. Teaser material goes out without an NDA. A limited Phase 1 room opens after the NDA and supports indications of interest. The full Phase 2 room opens after a signed LOI. Payer rates, named physician pay and referral data open last, through a clean team, close to signing.
What is a clean team and when does a healthcare seller need one?
A clean team is a small group of buyer reviewers, usually outside advisors, who see competitively sensitive data that the buyer's operators do not. You need one when the buyer competes with you or contracts with the same payers and referral sources. The clean team agreement controls access. The buyer also has to separate people and systems in practice, and what competitors may lawfully exchange is a separate antitrust question.
Why do buyers ask for exclusion screening records?
An excluded provider, employee or vendor connected to federal program claims creates repayment exposure that follows the business after closing. Buyers want monthly screening logs against the HHS OIG exclusion list, SAM.gov and the state Medicaid exclusion lists, covering every provider, employee and vendor. A practice that screens only at hire should run a full lookback before launch.
How many folders should a healthcare data room have?
Use seven working folders plus a Read Me First file and a restricted clean team folder. Number the folders, keep subfolders to two levels and use one file naming convention throughout. Buyers judge how well a business is run partly by how quickly they can find the documents behind its numbers.
Sources
- SRS Acquiom, 2026 Deal Terms for M&A Escrows (2025 deal data, all industries)
- SRS Acquiom, 2026 M&A Earnout and Milestone Trends (2025 deals vs 2014 to 2022)
- Private Equity Stakeholder Project, Private Equity Healthcare Deals: 2025 in Review (PitchBook and LevinPro HC data)
- Becker's ASC Review, The outpatient specialties that dominated 2025 deal activity (PESP data)
- FOCUS Investment Banking, Dermatology Practice Valuation: 2026 Benchmarks (includes LevinPro HC eHealth data)
- Kaufman Hall, Q3 2026 M&A Quarterly Activity Report release, October 13, 2026
- CMS, National Health Expenditure fact sheet (2024 data)
- U.S. Bureau of Labor Statistics, Health Care and Social Assistance industry page
- SEC EDGAR full-text search
- FINRA BrokerCheck
- HHS OIG, Exclusions program